As Ventus Therapeutics expanded across the United States and Canada, rapid growth increased the complexity of its laboratory purchasing and financial operations.

• Administrative strain: Scientists spent valuable research time on manual purchasing tasks without dedicated lab operations support.

• Increasing order volume: A lean accounts payable team faced a growing workload as the company scaled.

• Limited visibility: Decentralized purchasing made financial reporting, spend management, and documented controls more difficult.

To scale efficiently and maintain research velocity, Ventus implemented Prendio-BioProcure’s biotech procurement software and services.

• Automated three-way matching: A key factor in Ventus’s decision, the feature improved accuracy and control across purchase orders, receipts, invoices, and payments.

• Seamless onboarding: More than 50 users adopted the platform smoothly, with purchasing and approval workflows aligned to existing processes.

• Integrated procurement support: Technology and services helped Ventus manage growing purchasing demands without adding operational burden.

Ventus achieved measurable results through a biotech procurement transformation that lowered costs, reduced administrative work, and improved financial visibility.

• $150K+ in cost savings that Ventus could reinvest in advancing its scientific programs.

• Hundreds of hours saved by automating purchase approvals, ordering, and invoice workflows.

• Stronger supplier relationships and greater accuracy through automated invoice processing and financial tracking.